Role of prostaglandins, prostacyclin, and thromboxanes in the physiologic control of the uterus and in parturition.
D000818:Animals; D003238:Connective Tissue / Q000502:physiology; D016861:Cyclooxygenase Inhibitors; D004717:Endometrium / Q000502:physiology; D011464:Epoprostenol / Q000502:physiology*; D005260:Female; D006801:Humans; D007743:Labor, Obstetric / Q000187:drug effects; D008954:Models, Biological; D009215:Myometrium / Q000502:physiology; D010121:Oxytocin / Q000494:pharmacology; D010920:Placenta / Q000502:physiology; D011247:Pregnancy; D011448:Prostaglandin Antagonists; D011453:Prostaglandins / Q000096:biosynthesis / Q000502:physiology* / Q000627:therapeutic use; D013045:Species Specificity; D013931:Thromboxanes / Q000502:physiology*; D014590:Uterine Contraction; D014599:Uterus / Q000098:blood supply / Q000502:physiology*
D016861:Cyclooxygenase Inhibitors; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D013931:Thromboxanes; D010121:Oxytocin; D011464:Epoprostenol